115 related articles for article (PubMed ID: 34126859)
41. Development of a Chitosan-based Nanoparticle Formulation for Ophthalmic Delivery of Honokiol.
Deng F; Hu W; Chen H; Tang Y; Zhang L
Curr Drug Deliv; 2018; 15(4):594-600. PubMed ID: 28425869
[TBL] [Abstract][Full Text] [Related]
42. An alternative test battery in detecting ocular irritancy of agrochemicals.
Tavaszi J; Budai P; Pálovics A; Kismányoki A
Commun Agric Appl Biol Sci; 2008; 73(4):891-5. PubMed ID: 19226840
[TBL] [Abstract][Full Text] [Related]
43. Self-nanoemulsifying drug delivery system to improve transcorneal permeability of voriconazole: in-vivo studies.
Rasoanirina BNV; Lassoued MA; Miladi K; Razafindrakoto Z; Chaâbane-Banaoues R; Ramanitrahasimbola D; Cornet M; Sfar S
J Pharm Pharmacol; 2020 Jul; 72(7):889-896. PubMed ID: 32294801
[TBL] [Abstract][Full Text] [Related]
44. In-situ forming gels containing fluorometholone-loaded polymeric nanoparticles for ocular inflammatory conditions.
Gonzalez-Pizarro R; Carvajal-Vidal P; Halbault Bellowa L; Calpena AC; Espina M; García ML
Colloids Surf B Biointerfaces; 2019 Mar; 175():365-374. PubMed ID: 30554015
[TBL] [Abstract][Full Text] [Related]
45. Novel in situ gelling ophthalmic drug delivery system based on gellan gum and hydroxyethylcellulose: Innovative rheological characterization, in vitro and in vivo evidence of a sustained precorneal retention time.
Destruel PL; Zeng N; Seguin J; Douat S; Rosa F; Brignole-Baudouin F; Dufaÿ S; Dufaÿ-Wojcicki A; Maury M; Mignet N; Boudy V
Int J Pharm; 2020 Jan; 574():118734. PubMed ID: 31705970
[TBL] [Abstract][Full Text] [Related]
46. Ocular ketoconazole-loaded proniosomal gels: formulation, ex vivo corneal permeation and in vivo studies.
Abdelbary GA; Amin MM; Zakaria MY
Drug Deliv; 2017 Nov; 24(1):309-319. PubMed ID: 28165809
[TBL] [Abstract][Full Text] [Related]
47. Diclofenac sodium loaded PLGA nanoparticles for inflammatory diseases with high anti-inflammatory properties at low dose: Formulation, characterization and in vivo HET-CAM analysis.
Öztürk AA; Namlı İ; Güleç K; Kıyan HT
Microvasc Res; 2020 Jul; 130():103991. PubMed ID: 32105668
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of Ocular Irritation and Bioavailability of Voriconazole Loaded Microemulsion.
Kumar R; Sinha VR
Curr Drug Deliv; 2017; 14(5):718-724. PubMed ID: 27538459
[TBL] [Abstract][Full Text] [Related]
49. Fabrication of a drug delivery system that enhances antifungal drug corneal penetration.
Li J; Li Z; Liang Z; Han L; Feng H; He S; Zhang J
Drug Deliv; 2018 Nov; 25(1):938-949. PubMed ID: 29658325
[TBL] [Abstract][Full Text] [Related]
50. Formulation and evaluation of thermosensitive flurbiprofen
Maddiboyina B; Jhawat V; Desu PK; Gandhi S; Nakkala RK; Singh S
J Biomater Sci Polym Ed; 2021 Aug; 32(12):1584-1597. PubMed ID: 33977874
[TBL] [Abstract][Full Text] [Related]
51. Fabrication of a composite system combining solid lipid nanoparticles and thermosensitive hydrogel for challenging ophthalmic drug delivery.
Hao J; Wang X; Bi Y; Teng Y; Wang J; Li F; Li Q; Zhang J; Guo F; Liu J
Colloids Surf B Biointerfaces; 2014 Feb; 114():111-20. PubMed ID: 24176890
[TBL] [Abstract][Full Text] [Related]
52. Nanoemulsion as a feasible and biocompatible carrier for ocular delivery of travoprost: Improved pharmacokinetic/pharmacodynamic properties.
Ismail A; Nasr M; Sammour O
Int J Pharm; 2020 Jun; 583():119402. PubMed ID: 32387308
[TBL] [Abstract][Full Text] [Related]
53. Integrated nanovesicular/self-nanoemulsifying system (INV/SNES) for enhanced dual ocular drug delivery: statistical optimization, in vitro and in vivo evaluation.
Yousry C; Zikry PM; Salem HM; Basalious EB; El-Gazayerly ON
Drug Deliv Transl Res; 2020 Jun; 10(3):801-814. PubMed ID: 31989414
[TBL] [Abstract][Full Text] [Related]
54. Formulation and evaluation of Ketoconazole niosomal gel drug delivery system.
Shirsand S; Para M; Nagendrakumar D; Kanani K; Keerthy D
Int J Pharm Investig; 2012 Oct; 2(4):201-7. PubMed ID: 23580936
[TBL] [Abstract][Full Text] [Related]
55. Ocular supersaturated self-nanoemulsifying drug delivery systems (S-SNEDDS) to enhance econazole nitrate bioavailability.
Elkasabgy NA
Int J Pharm; 2014 Jan; 460(1-2):33-44. PubMed ID: 24184217
[TBL] [Abstract][Full Text] [Related]
56. Ocular amphotericin B delivery by chitosan-modified nanostructured lipid carriers for fungal keratitis-targeted therapy.
Fu T; Yi J; Lv S; Zhang B
J Liposome Res; 2017 Sep; 27(3):228-233. PubMed ID: 27601177
[TBL] [Abstract][Full Text] [Related]
57. Glycerogelatin-based ocular inserts of aceclofenac: physicochemical, drug release studies and efficacy against prostaglandin E₂-induced ocular inflammation.
Mathurm M; Gilhotra RM
Drug Deliv; 2011 Jan; 18(1):54-64. PubMed ID: 20718601
[TBL] [Abstract][Full Text] [Related]
58. Delineating penetration enhancer-enriched liquid crystalline nanostructures as novel platforms for improved ophthalmic delivery.
El-Gendy MA; Mansour M; El-Assal MIA; Ishak RAH; Mortada ND
Int J Pharm; 2020 May; 582():119313. PubMed ID: 32283196
[TBL] [Abstract][Full Text] [Related]
59. Comparison of systemic absorption between ofloxacin ophthalmic in situ gels and ofloxacin conventional ophthalmic solutions administration to rabbit eyes by HPLC-MS/MS.
Li J; Zhao H; Okeke CI; Li L; Liu Z; Yin Z; Zhuang P; Sun J; Wu T; Wang M; Li N; Pi J; Zhang Q; Zhang R; Ma L; Pang X; Liu Z; Zhang L; Fan L
Int J Pharm; 2013 Jun; 450(1-2):104-13. PubMed ID: 23612359
[TBL] [Abstract][Full Text] [Related]
60. Nanosuspension as an Efficient Carrier for Improved Ocular Permeation of Voriconazole.
Qin T; Dai Z; Xu X; Zhang Z; You X; Sun H; Liu M; Zhu H
Curr Pharm Biotechnol; 2021; 22(2):245-253. PubMed ID: 32867650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
